Diabetic Macular Edema (DME) Recruiting Phase 4 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03056092Cytokine and Visual Outcome Variations in Eyes Receiving RanibizumabTreatment
NCT03690947Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DMETreatment
NCT03832179Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to PhacoemulsificationTreatment
NCT03458923Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.Treatment
NCT03097068Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg LucentisBasic Science